Roseburia intestinalis: A Beneficial Gut Organism From the Discoveries in Genus and Species

Roseburia intestinalis is an anaerobic, Gram-positive, slightly curved rod-shaped flagellated bacterium that produces butyrate in the colon. R. intestinalis has been shown to prevent intestinal inflammation and maintain energy homeostasis by producing metabolites. Evidence shows that this bacterium...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kai Nie, Kejia Ma, Weiwei Luo, Zhaohua Shen, Zhenyu Yang, Mengwei Xiao, Ting Tong, Yuanyuan Yang, Xiaoyan Wang
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/209ac82b7d0e4a4b8e2a77339a4a7a0d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:209ac82b7d0e4a4b8e2a77339a4a7a0d
record_format dspace
spelling oai:doaj.org-article:209ac82b7d0e4a4b8e2a77339a4a7a0d2021-11-30T10:16:00ZRoseburia intestinalis: A Beneficial Gut Organism From the Discoveries in Genus and Species2235-298810.3389/fcimb.2021.757718https://doaj.org/article/209ac82b7d0e4a4b8e2a77339a4a7a0d2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fcimb.2021.757718/fullhttps://doaj.org/toc/2235-2988Roseburia intestinalis is an anaerobic, Gram-positive, slightly curved rod-shaped flagellated bacterium that produces butyrate in the colon. R. intestinalis has been shown to prevent intestinal inflammation and maintain energy homeostasis by producing metabolites. Evidence shows that this bacterium contributes to various diseases, such as inflammatory bowel disease, type 2 diabetes mellitus, antiphospholipid syndrome, and atherosclerosis. This review reveals the potential therapeutic role of R. intestinalis in human diseases. Patients with inflammatory bowel disease exhibit significant changes in R. intestinalis abundance, and they may benefit a lot from modulations targeting R. intestinalis. The data reviewed here demonstrate that R. intestinalis plays its role in regulating barrier homeostasis, immune cells, and cytokine release through its metabolite butyrate, flagellin and other. Recent advancements in the application of primary culture technology, culture omics, single-cell sequencing, and metabonomics technology have improved research on Roseburia and revealed the benefits of this bacterium in human health and disease treatment.Kai NieKai NieKejia MaKejia MaWeiwei LuoWeiwei LuoZhaohua ShenZhaohua ShenZhenyu YangZhenyu YangMengwei XiaoMengwei XiaoTing TongTing TongYuanyuan YangYuanyuan YangXiaoyan WangXiaoyan WangFrontiers Media S.A.articleRoseburiaRoseburia intestinalisprobioticinflammatory bowel disease (IBD)microbiomeMicrobiologyQR1-502ENFrontiers in Cellular and Infection Microbiology, Vol 11 (2021)
institution DOAJ
collection DOAJ
language EN
topic Roseburia
Roseburia intestinalis
probiotic
inflammatory bowel disease (IBD)
microbiome
Microbiology
QR1-502
spellingShingle Roseburia
Roseburia intestinalis
probiotic
inflammatory bowel disease (IBD)
microbiome
Microbiology
QR1-502
Kai Nie
Kai Nie
Kejia Ma
Kejia Ma
Weiwei Luo
Weiwei Luo
Zhaohua Shen
Zhaohua Shen
Zhenyu Yang
Zhenyu Yang
Mengwei Xiao
Mengwei Xiao
Ting Tong
Ting Tong
Yuanyuan Yang
Yuanyuan Yang
Xiaoyan Wang
Xiaoyan Wang
Roseburia intestinalis: A Beneficial Gut Organism From the Discoveries in Genus and Species
description Roseburia intestinalis is an anaerobic, Gram-positive, slightly curved rod-shaped flagellated bacterium that produces butyrate in the colon. R. intestinalis has been shown to prevent intestinal inflammation and maintain energy homeostasis by producing metabolites. Evidence shows that this bacterium contributes to various diseases, such as inflammatory bowel disease, type 2 diabetes mellitus, antiphospholipid syndrome, and atherosclerosis. This review reveals the potential therapeutic role of R. intestinalis in human diseases. Patients with inflammatory bowel disease exhibit significant changes in R. intestinalis abundance, and they may benefit a lot from modulations targeting R. intestinalis. The data reviewed here demonstrate that R. intestinalis plays its role in regulating barrier homeostasis, immune cells, and cytokine release through its metabolite butyrate, flagellin and other. Recent advancements in the application of primary culture technology, culture omics, single-cell sequencing, and metabonomics technology have improved research on Roseburia and revealed the benefits of this bacterium in human health and disease treatment.
format article
author Kai Nie
Kai Nie
Kejia Ma
Kejia Ma
Weiwei Luo
Weiwei Luo
Zhaohua Shen
Zhaohua Shen
Zhenyu Yang
Zhenyu Yang
Mengwei Xiao
Mengwei Xiao
Ting Tong
Ting Tong
Yuanyuan Yang
Yuanyuan Yang
Xiaoyan Wang
Xiaoyan Wang
author_facet Kai Nie
Kai Nie
Kejia Ma
Kejia Ma
Weiwei Luo
Weiwei Luo
Zhaohua Shen
Zhaohua Shen
Zhenyu Yang
Zhenyu Yang
Mengwei Xiao
Mengwei Xiao
Ting Tong
Ting Tong
Yuanyuan Yang
Yuanyuan Yang
Xiaoyan Wang
Xiaoyan Wang
author_sort Kai Nie
title Roseburia intestinalis: A Beneficial Gut Organism From the Discoveries in Genus and Species
title_short Roseburia intestinalis: A Beneficial Gut Organism From the Discoveries in Genus and Species
title_full Roseburia intestinalis: A Beneficial Gut Organism From the Discoveries in Genus and Species
title_fullStr Roseburia intestinalis: A Beneficial Gut Organism From the Discoveries in Genus and Species
title_full_unstemmed Roseburia intestinalis: A Beneficial Gut Organism From the Discoveries in Genus and Species
title_sort roseburia intestinalis: a beneficial gut organism from the discoveries in genus and species
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/209ac82b7d0e4a4b8e2a77339a4a7a0d
work_keys_str_mv AT kainie roseburiaintestinalisabeneficialgutorganismfromthediscoveriesingenusandspecies
AT kainie roseburiaintestinalisabeneficialgutorganismfromthediscoveriesingenusandspecies
AT kejiama roseburiaintestinalisabeneficialgutorganismfromthediscoveriesingenusandspecies
AT kejiama roseburiaintestinalisabeneficialgutorganismfromthediscoveriesingenusandspecies
AT weiweiluo roseburiaintestinalisabeneficialgutorganismfromthediscoveriesingenusandspecies
AT weiweiluo roseburiaintestinalisabeneficialgutorganismfromthediscoveriesingenusandspecies
AT zhaohuashen roseburiaintestinalisabeneficialgutorganismfromthediscoveriesingenusandspecies
AT zhaohuashen roseburiaintestinalisabeneficialgutorganismfromthediscoveriesingenusandspecies
AT zhenyuyang roseburiaintestinalisabeneficialgutorganismfromthediscoveriesingenusandspecies
AT zhenyuyang roseburiaintestinalisabeneficialgutorganismfromthediscoveriesingenusandspecies
AT mengweixiao roseburiaintestinalisabeneficialgutorganismfromthediscoveriesingenusandspecies
AT mengweixiao roseburiaintestinalisabeneficialgutorganismfromthediscoveriesingenusandspecies
AT tingtong roseburiaintestinalisabeneficialgutorganismfromthediscoveriesingenusandspecies
AT tingtong roseburiaintestinalisabeneficialgutorganismfromthediscoveriesingenusandspecies
AT yuanyuanyang roseburiaintestinalisabeneficialgutorganismfromthediscoveriesingenusandspecies
AT yuanyuanyang roseburiaintestinalisabeneficialgutorganismfromthediscoveriesingenusandspecies
AT xiaoyanwang roseburiaintestinalisabeneficialgutorganismfromthediscoveriesingenusandspecies
AT xiaoyanwang roseburiaintestinalisabeneficialgutorganismfromthediscoveriesingenusandspecies
_version_ 1718406671285354496